CoChat
Sign Up
Cited by 157Posttraumatic Stress Disorder ResearchMigration, Health and TraumaTreatment of Major Depression

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Venlafaxine Extended Release in Posttraumatic Stress Disorder: A Sertraline- and Placebo-controlled Study

Davidson, Jonathan, Rothbaum, Barbara O., Tucker, Phebe, Asnis, Gregory, Benattia, Isma, Musgnung, Jeff J.·2006·Journal of Clinical Psychopharmacology
DOI 10.1097/01.jcp.0000222514.71390.c1
Open this paper in CoChat — free account

Abstract

This 12-week, double-blind, multicenter trial evaluated the efficacy of venlafaxine extended release (ER), sertraline, and placebo in adult outpatients (N = 538) with a primary diagnosis of posttraumatic stress disorder (PTSD), as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, symptoms for 6 months or more and 17-item Clinician-administered PTSD Scale (CAPS-SX17) score of 60 or more. Patients were randomly assigned to receive placebo or flexible doses of venlafaxine ER (37.5-300 mg/d) or sertraline (25-200 mg/d) for 12 weeks or less. The primary outcome was the baseline-to-end point change in total CAPS-SX17 score (last observation carried forward). Secondary measures included CAPS-SX17 symptom cluster scores for reexperiencing/intrusion, avoidance/numbing, and hyperarousal; frequency of remission (CAPS-SX17 < or =20); and changes in Davidson Trauma Scale total score and symptom cluster scores for avoidance/numbing, hyperarousal, and reexperiencing/intrusion. Mean changes in CAPS-SX17 scores were -41.8, -39.4, and -33.9 for venlafaxine ER (P < 0.05 vs. placebo), sertraline, and placebo, respectively. Mean changes for venlafaxine ER, sertraline, and placebo in CAPS-SX17 cluster scores were -13.0, -11.7, and -11.0 for reexperiencing; -17.1, -16.8, and -13.7 (P < 0.05 both active treatments vs. placebo) for avoidance/numbing; and -11.8, -10.9, and -9.2 (P < 0.05 venlafaxine vs. placebo) for hyperarousal. Week 12 remission rates were venlafaxine ER 30.2% (P < 0.05 vs. placebo), sertraline 24.3%, and placebo 19.6%. The venlafaxine ER group had significantly better Davidson Trauma Scale total and cluster scores than placebo. Mean maximum daily doses were 225-mg venlafaxine ER and 151-mg sertraline. Both treatments were generally well tolerated. Study results suggest that venlafaxine ER is effective and well tolerated in the short-term treatment of PTSD.

Overview

Integrity signals

Registry

Crossref · 10.1097/01.jcp.0000222514.71390.c1

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Cited by

Sorted by citations

See all 157

Related

Metadata

Authors
Davidson, J., Rothbaum, B. O., Tucker, P., Asnis, G., Benattia, I., & Musgnung, J. J.
Affiliations
  • Duke University (US)
  • Emory University (US)
  • OU Health (US)
  • Albert Einstein College of Medicine (US)
  • Wyeth (US)
Corresponding author
Davidson, Jonathan
ORCID
Venue
Journal of Clinical Psychopharmacology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2006-06
Volume
26
Issue
3
Pages
259-267
ISSN
0271-0749 (ISSN-L)
DOI
10.1097/01.jcp.0000222514.71390.c1
OpenAlex
W2066358721
Cited by
157
References
41
Citations by year
2026: 2 · 2025: 5 · 2024: 10 · 2023: 6 · 2022: 8 · 2021: 3 · 2020: 6 · 2019: 3 · 2018: 6 · 2017: 8 · 2016: 8 · 2015: 10 · 2014: 9 · 2013: 9 · 2012: 9
FWCI
13.25
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Social Sciences › Psychology › Clinical Psychology › Migration, Health and Trauma
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
post-traumatic stress disorder, sertraline, selective serotonin reuptake inhibitors, antidepressant efficacy, symptom remission, re-experiencing, avoidance and numbing, hyperarousal, outpatients, flexible dosing, Davidson Trauma Scale, treatment-resistant PTSD, adverse events
MeSH terms
Venlafaxine Hydrochloride, Adolescent, Adult, Cyclohexanols, Delayed-Action Preparations, Double-Blind Method, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Stress Disorders, Post-Traumatic, Antidepressive Agents, Second-Generation, Sertraline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review